Sale of shares in Hansa Biopharma AB (publ)
Press release Stockholm 26 August 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Nexttobe AB (“Nexttobe”) has sold 3.6 million shares in Hansa Biopharma AB (publ) ("Hansa Biopharma") through an accelerated bookbuilding to Swedish and international institutional investors at a price of SEK 240 per share (the “Share Sale”). Following the Share Sale, Nexttobe owns 2,155,379 shares in Hansa Biopharma, corresponding